Mafenide acetate in burn treatment.
D000136:Acid-Base Equilibrium / Q000187:drug effects*; D002056:Burns / Q000188:drug therapy*; D002245:Carbon Dioxide / Q000097:blood; D002257:Carbonic Anhydrase Inhibitors / Q000627:therapeutic use*; D006863:Hydrogen-Ion Concentration; D006955:Hypernatremia / Q000139:chemically induced; D006985:Hyperventilation / Q000139:chemically induced; D007008:Hypokalemia / Q000139:chemically induced; D011188:Potassium / Q000652:urine; D013449:Sulfonamides / Q000009:adverse effects / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use*; D014050:Toluene / Q000627:therapeutic use
D002257:Carbonic Anhydrase Inhibitors; D013449:Sulfonamides; D002245:Carbon Dioxide; D014050:Toluene; D011188:Potassium